Tag: Prescription Drugs
Most IV HTN Meds Ordered for Patients With SBP <180 mm Hg
Drugs administered in patients with uncontrolled BP for levels not linked to immediate CV risk
New Drug Looks Promising for Respiratory Syncytial Virus
Amount of virus was reduced 85 to 88 percent, compared with those who received the placebo
Sofosbuvir-Velpatasvir Successful in Hep C Regardless of Genotype
Three studies show high sustained virologic response rates, regardless of HCV genotype
Three-Month Efficacy Data Predicts Six-Month RA Tx Efficacy
ΔACR50 at six months was strongly correlated with results obtained at three months
Risk of Anaphylaxis Among IV Iron Products Compared
Risk of anaphylaxis associated with IV iron highest for iron dextran, lowest for iron sucrose
HbA1c Control on Metformin Predicts Durable Control in T2DM
HbA1c cut-off of 6.3 percent differentiated teens that remained in glycemic control, lost control
Intervention Cuts Potentially Inappropriate Meds in Seniors
Intervention also effective for reducing proton pump inhibitor prescribing
Levodopa Shows Promise Against Macular Degeneration
But more research needed to confirm beneficial effects on vision disorder
Incretin Use May Up Pancreatic CA Risk, but Only in Short Term
With prolonged use, risk decreased to baseline levels
AHA: Infrequent Monitoring for Heart Failure Patients on MRAs
Low monitoring rates in clinical practice in patients initiating mineralocorticoid receptor antagonists
